Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P67
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
4 yr
Consecutive growthAccelerating
PeriodValue
2024-18.43%
2023-49.39%
2022-77.73%
2021-162.34%
2020-1761.63%
201979.61%
20180.00%